Sara Lorenz Taki, MD

Dr. Sara Lorenz Taki is medical director of Greenwich House’s Methadone Maintenance Treatment Program. Since joining the organization in 2017, Dr. Taki has medical oversight for nearly 1,000 patients with opioid use disorder, that she treats using the life-saving medications methadone and buprenorphine. She develops and oversees all health services, including medication-assisted treatment, hepatitis c treatment, overdose prevention, psychiatric services, and the Greenwich House COVID-19 vaccination program.

Dr. Taki is committed to bringing live-saving methadone and buprenorphine treatment to people with opioid addiction and to fighting stigma. She is committed to providing evidence-based, patient-centered addiction treatment that supports and empowers patients in meeting their life and recovery goals.

Dr. Taki has special interest in the integration of harm reduction into opioid treatment programs, treatment of hepatitis c, women’s health, and the management of medically complex patients. Dr. Taki strives to lower barriers to care so that all who need treatment can access it.

Dr. Taki is an associate professor in the department of medicine at NYU. She also trains physicians from the Institute for Family Health’s addiction medicine fellowship on the use of methadone for treatment of opioid use disorder.

 Dr. Taki currently serves on the Clinical Advisory Panel for OASAS and the Substance Use Guidelines Committee for the New York State Department of Health AIDS Institute. She is a member of the American Society of Addiction Medicine and a frequent speaker for the Empire Liver Foundation on hepatitis c treatment in people who use drugs.

Prior to Greenwich House, Dr. Taki worked as Unit Medical Director at Mount Sinai Beth Israel’s Opioid Treatment Program and as a primary care provider at Montefiore Medical Center.

Dr. Taki obtained her Bachelor’s degree in Medical Microbiology and Immunology from the University of Wisconsin – Madison and her medical degree from the University of Wisconsin School of Medicine and Public Health. She is board certified in addiction medicine and internal medicine.